News Archive

/News Archive/

Xeltis’ restorative technology at Biomaterials

2019-06-11T12:52:57+00:00April 3rd, 2019|Latest News|

Preclinical data on Xeltis’ restorative heart valves will illustrate supramolecular materials’ potential application in clinical practice at the Society for Biomaterials annual meeting on Thursday 4 April. Xeltis CTO Martijn Cox will present 2-year preclinical data outlining the capability [...]

Xeltis’ RestoreX™ in Cardiovascular Pathology

2019-06-11T12:55:58+00:00March 8th, 2019|Latest News|

Peer-reviewed journal Cardiovascular Pathology published positive one-year in-vivo data on Xeltis’ RestoreX™ technology platform in its latest issue. According to the paper, preclinical results of RestoreX™ pulmonary graft confirmed the potential of Xeltis’ restorative cardiovascular approach. The study showed that [...]

Xeltis’ new leadership functional to next phase

2019-06-11T12:58:38+00:00March 1st, 2019|Latest News|

Mohammed El-Kurdi, PhD, Vice President for Tissue Science, and Luc Verhees, Senior Vice President for Clinical, Pre-clinical and Medical Affairs, joined Acting CEO Eliane Schutte - Xeltis CDO since 2016 - and CTO and Co-founder Martijn Cox on Xeltis’ leadership [...]

Xeltis data shortlisted at EACTS Techno-College Innovation Award

2019-02-14T11:30:53+00:00October 19th, 2018|News|

An abstract on Xeltis clinical data has been shortlisted as one of five finalists at the EACTS Techno-College Innovation Award. Professor Tomasz Mroczek from the Children’s University Hospital, Krakow, Poland will present 1-year Xeltis data on the “First clinical experience [...]

Xeltis’ New Chairman and Board Member

2019-02-14T11:32:27+00:00September 24th, 2018|News|

Xeltis has welcomed Stefan K. Widensohler as the new Chairman of the Board, following his nomination by Xeltis Board members. Stefan has over 25 years of experience as a healthcare entrepreneur and has been an active investor and board member [...]

Xeltis’ aortic valve one of highest peer-review oral abstracts at TCT

2019-02-14T11:33:48+00:00September 18th, 2018|News|

Initial in vivo experience on Xeltis’ restorative aortic valve will feature as one of the highest peer-reviewed oral abstracts of TCT 2018. Professor Christian Spaulding, Chief, Interventional Cardiology, European Hospital Georges Pompidou, Paris (F), will present long-term pre-clinical on Xeltis’ [...]

Xeltis’ restorative technology featured at ISACB

2019-02-14T11:34:45+00:00September 14th, 2018|News|

Preclinical data on Xeltis’ restorative heart valve technology will feature at the 16th International Society of Applied Cardiovascular Biology (ISACB) Biennial meeting. Professor Frederick J. Schoen from Harvard Medical School will present 1-year preclinical data outlining the capability of Xeltis [...]

Load More Posts